Related Experiment Video
Updated: Mar 24, 2026

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
Published on: December 16, 2021
MYC-ATF4-ASS1 axis governs intracellular arginine synthesis and dictates the immune microenvironment in melanoma
Haiwei Mou1, Veronika Yakovishina1, Yeqing Chen1
1Melanoma Research Center, Molecular and Cellular Biology Program, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104.
Abstract:
Drug resistance is a major challenge for both targeted therapies and immunotherapies in cancer. Arginine starvation has proven a promising strategy to overcome recurrent tumors. However, key molecules involved and how immune responses are elicited are not well understood. Here we identify in melanoma cells MYC-ATF4-ASS1 signaling as a pathway, which not only governs intracellular arginine synthesis but also modulates antitumor immunity. ATF4 knockout in melanoma cells phenocopied ASS1 knockout in the same cells, both showing greater sensitivity to arginine depletors such as ADI-PEG20. A combination strategy of BRAF/MEK inhibitors and an arginine depletor shows significant therapeutic effects in a immune-compromised mouse model. Both Atf4 and Ass1 knockout melanomas exhibited enhanced infiltration of Cd8+ T cells and significantly reduced tumor growth in a syngeneic mouse model. Single cell transcriptomics profiled the reshaped tumor microenvironment and revealed that a subset of resident macrophages were reprogrammed by endogenous arginine blockade. Overall, our findings reveal that the MYC-ATF4-ASS1 axis not only controls arginine vulnerability of melanomas but also shapes the immune microenvironment.
Insights
MYC-ATF4-ASS1 signaling controls melanoma
Area of Science:
- Oncology
- Cancer Immunology
- Molecular Biology
Background:
- Drug resistance in cancer limits targeted and immunotherapy efficacy.
- Arginine starvation is a potential strategy against recurrent tumors, but underlying mechanisms and immune modulation are unclear.
Purpose of the Study:
- To identify key molecules in arginine metabolism and their role in melanoma's immune response.
- To investigate the MYC-ATF4-ASS1 pathway's function in melanoma cell arginine synthesis and immune modulation.
Main Methods:
- Utilized ATF4 knockout and Argininosuccinate Synthetase 1 (ASS1) knockout in melanoma cells.
- Employed a combination therapy of BRAF/MEK inhibitors and an arginine depletor in immunocompromised mice.
- Conducted experiments in syngeneic mouse models with knockout melanomas.
- Performed single-cell transcriptomics to analyze the tumor microenvironment.
Main Results:
- ATF4 knockout mirrored ASS1 knockout, increasing sensitivity to arginine depletors like ADI-PEG20.
- Combined BRAF/MEK inhibitors and arginine depletion showed therapeutic effects in mice.
- Atf4 and Ass1 knockout melanomas displayed increased CD8+ T cell infiltration and reduced tumor growth.
- Single-cell transcriptomics revealed macrophage reprogramming due to endogenous arginine blockade.
Conclusions:
- The MYC-ATF4-ASS1 axis regulates melanoma's arginine synthesis and vulnerability.
- This pathway significantly shapes the tumor immune microenvironment, influencing T cell infiltration and macrophage activity.
- Targeting this axis offers a novel strategy for overcoming drug resistance and enhancing anti-tumor immunity.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
MAPK Signaling Cascades
The Tumor Microenvironment
Induced Pluripotent Stem Cells
Somatic...

